Ageing and Fertility: Biology Comes Second
By Kirsty Oswald,
BioNews
| 08. 10. 2015
The association between a woman's age and her fertility never seems far from the news but recently there has been a veritable bombardment of opinion over what age a woman should have a child.
We are repeatedly reminded that a woman's fertility drops off a cliff after age 40. Or was it 35? Or 38? I don't remember. And it depends which week you ask.
How does this keep making headlines time and time again, when each finding seems so unauthoritative and inconsistent it might as well have been picked from a hat?
It would appear we cannot resist a biologically authorised opportunity to tell a woman what to do with her body. But all this talk of the age a woman's fertility 'drops off a cliff' is just a distractor from the truth – this phenomenon of women finding themselves 'up against' the biological clock is a cultural one, not a biological one.
Read more...
Image via Wikimedia Commons.
Related Articles
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Alexandra Marquez, NBC News | 03.13.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...